
å éšåçºè ã¯é£éŠä¿å¥æ©é¢ãCOVIDã¯ã¯ãã³ã«ããæå·ãé èœããŠããããšãæŽé²
å èšäºã¯ãã¡ããã/Click here to read the original article.
ãã³ã»ãžã§ã³ãœã³äžé¢è°å¡ã¯ãé£éŠä¿å¥æ©é¢ãCOVID-19ã¯ã¯ãã³ã®æå·ããŒã¿ãé èœãããšäž»åŒµããŠãããããã¯åœŒã®ç涯ã§ãæå€§ã®æ¿åºã¹ãã£ã³ãã«ãã§ãããšè¿°ã¹ãŠããã
VAERSã®ããŒã¿ã«ãããšãã³ããã¯ã¯ãã³ã«é¢é£ããŠå ±åãããæ»äº¡ã¯21,000人ã§ãã£ãã®ã«å¯Ÿããä»ã®ãã¹ãŠã®ã¯ã¯ãã³ãåããã幎éå¹³åã¯280人ã§ãã£ãã
ç±³åœé£åå»è¬åå±ã®ã¢ããªã¹ãã¯ãå¿èçªç¶æ»ããã³ãã«éº»çºãå«ã25ã®å®å šã·ã°ãã«ãç¹å®ããããåœå±ã¯èª¿æ»ãäžæ¢ãããšãããŠããã
Johnsonæ°ã«ãããšãNIHã®ç ç©¶è ãã¯2021幎ã«ã¯ã¯ãã³ã§è² å·ããæ£è ãæ²»çããããäžè¬ã®äººã ã«ã¯çµæãå ¬è¡šããªãã£ãã
CDCãšFDAã¯ãCOVIDã¯ã¯ãã³ã®æå¹æ§ã瀺ãç ç©¶ã®çºè¡šã黿¢ããŠãããæ¹è©å®¶ã¯ãããæ€é²ãšåŠšå®³è¡çºãšåŒãã§ããã
é·å¹Žã«ãããè°äŒã®èª¿æ»ãšæ å ±èªç±æ³ã®èŠè«ã«ãããé£éŠä¿å¥åœå±ãCOVID-19ã¯ã¯ãã³ã®æå·ããŒã¿ãç±³åœæ°ããæ æã«é ããŠãã蚌æ ãæããã«ãªããã€ã³ãã©ãŒã ãã»ã³ã³ã»ã³ããšæ¿åºã®éææ§ã«å¯Ÿããæžå¿µãé«ãŸã£ãŠããããã³ã»ãžã§ã³ãœã³äžé¢è°å¡ã¯ãé£éŠä¿å¥æ©é¢ãæ°åã³ããæµè¡æã«ç±³åœæ°ã«å¯ŸããŠãé©ãã»ã©ãäžéææ§ã瀺ãããã€ã³ãã©ãŒã ãã»ã³ã³ã»ã³ãã®æ©æµãã奪ã£ããšéé£ããŠããã
VAERSã®äžäžèŽ:280äººã®æ»äº¡ãã21,000人ãž
ã¯ã¯ãã³æå®³äºè±¡å ±åã·ã¹ãã ã¯ãã¯ã¯ãã³ã«ããæœåšçãªæå·ã远跡ããããã®äž»èŠãªã¡ã«ããºã ãšããŠé·ãéæ©èœããŠããŸãããéå»ã®ããŒã¿ã«ãããšã2021幎以åã®å šã¯ã¯ãã³ã§å¹Žéå¹³å280äººã®æ»äº¡ãå ±åãããŠããŸããCOVID-19ã®æ³šå°ãå°å ¥ãããåŸããã®æ°ã¯äžçäžã§21,000äººã®æ»äº¡ãå ±åãããŸããã
ãã³ã»ãžã§ã³ãœã³äžé¢è°å¡ã¯ãé£éŠåœå±ãå®å šäžã®åé¡ãç¥ã£ãŠããªããããããé èœããããšãã蚌æ ãšããŠããã®é£ãéããææããŠãããææ°ã®åææ¹æ³ãç¬èªã«é©çšããç±³åœé£åå»è¬åå±ã®ã¢ããªã¹ãã¯ãå¿èçªç¶æ»ãèºæ¢å¡ããã«éº»çºãªã©25ã®å®å šã·ã°ãã«ãç¹å®ãããåœå±ã¯ãã®ã¢ããªã¹ãã«èª¿æ»ãäžæ¢ããããæç€ºããå®å šã·ã°ãã«ãé ãããã«èšèšãããæ¬ é¥ã®ããã¢ã«ãŽãªãºã ã䜿ãç¶ãããšãããŠããã
ã¯ã¯ãã³ã§è² å·ããæ£è ã«å¯ŸããNIHã®ç§å¯ã®æ²»ç
ã¯ã¯ãã³ã®å°å ¥ããæ°ãæä»¥å ã«ãNIHã®ç ç©¶è ãã¯COVID-19泚å°ã§è² å·ããæ£è ã®èšºæãšæ²»çãéå§ããŸããããžã§ã³ãœã³æ°ã®èª¿æ»çµæã«ãããšããããã®ç ç©¶è ãã¯æ£è ã«å¯Ÿããå»åŠçãšæ å ±ãå ±æããåã«ç ç©¶ãå®äºããå¿ èŠããããšäž»åŒµããç ç©¶ã«ã€ããŠæ²é»ãå®ãããæç€ºããŸããã
NIHã¯2022幎ãŸã§ãã®ç ç©¶ãçºè¡šããªãã£ãããããã§ãå ¬è¡šãããããšãªããã¬ããªã³ããµãŒããŒã«çœ®ãããããžã§ã³ãœã³ã¯ããããæ å ±ã«åºã¥ããå»åŠç決å®ã«å¿ èŠãªæ å ±ãã¢ã¡ãªã«äººãã奪ã£ããšäž»åŒµããã
ããããã®æ³šå°ã«é¢ããŠã€ã³ãã©ãŒã ãã»ã³ã³ã»ã³ãã¯ãªãã£ãããšãžã§ã³ãœã³æ°ã¯è¿°ã¹ãNIHã¯ã¯ã¯ãã³ã§è² å·ããæ£è ãæ²»çããŠããããFDAã¯å®å šæ§ã·ã°ãã«ã®ååšãåŠå®ããŠãããšææããã
CDCãã¯ã¯ãã³ã®æå¹æ§ããŒã¿ã®å ¬è¡šã黿¢
2026幎4æãCDCã¯ãCOVID-19ã¯ã¯ãã³ãå¬å£ã®ææ¥ç§å蚺ããã³å ¥é¢ãåæžãããããšã瀺ãç§åŠçå ±åã®å ¬è¡šãäžæ¢ããŸããããã®å ±åæžã¯ãCDCã®ç§åŠç審æ»ããã»ã¹ãééããåŸãCDCã®ãžã§ã€ã»ãã¿ãã£ãªã€æé·ä»£çãæ¹æ³è«äžã®æžå¿µãçç±ã«å¯©æ»ãå»¶æããŸããã
å CDCè·å¡ã®Demetre Daskalakisã¯ããã®åãã¯åäŸã®ãªããã®ã§ãããšããã¬ãã¥ãŒãã¯ãªã¢ããCDCã®äž»èŠãªãžã£ãŒãã«ã«æ²èŒãããäºå®ã§ãã£ãå ±åæžããæå°éšã«ãã£ãŠãããã¯ãããããšãç¥ããªãã£ããšææããã
åãæ¹æ³è«ã¯ãããã1ãæåã«çºè¡šãããã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ã®ç ç©¶ãå«ããåŒåžåšç³»ãŠã€ã«ã¹ã«å¯Ÿããã¯ã¯ãã³ã®æå¹æ§ãè©äŸ¡ããããã«æ°å幎ã«ããã£ãŠäœ¿çšãããŠããŸããã
ç±³é£åå»è¬åå±ãã¯ã¯ãã³ã®å®å šæ§ãè£ä»ããç ç©¶ã黿¢
ç±³ãã¥ãŒãšãŒã¯ã»ã¿ã€ã ãºçŽã¯ãç±³é£åå»è¬åå±ãCOVID-19ãšåž¯ç¶ç±ç¹ã¯ã¯ãã³ã®å®å šæ§ãè£ä»ããè€æ°ã®ç ç©¶ã®å ¬è¡šã黿¢ãããšå ±ããŸããããããã®ç ç©¶ã¯æ°çŸäžãã«ã®å ¬çè³éãè²»ãããæ°çŸäžäººã®æ£è èšé²ãåæããé節ãªå¯äœçšã¯éåžžã«ãŸãã§ããããšãæããã«ããŸããã
ã¢ã¡ãªã«é£åå»è¬åå±ã®èŠå¶ãç ç©¶ããŠããããŒãŽã¡ãŒãã®å»åŠææã§ããã¢ãŒãã³ã»Sã»ã±ãã»ã«ãã€ã å士ã¯ãè«æã®æ€åèŠæ±ãæ€é²è¡çºãšåŒã³ãŸããã
ãæŽå²ã®ä»ã®ãããªãææã«ãããŠããããã¯è°äŒã®å ¬èŽäŒãšæå°éšã®èŸä»»ã«ã€ãªãã倧ããªã¹ãã£ã³ãã«ãšãªãã ããããšã±ãã»ã«ãã€ã æ°ã¯è¿°ã¹ãŸããã
NIHã®å é«å®ã§ããJeanne Marrazzoå士ã¯ãè«æã®çºè¡šäžæ¢ã¯ãããªãç©æ¥µçãªåŠšå®³è¡çºãã§ãããšè¿°ã¹ãã
äž»æµã¡ãã£ã¢ã®æ²é»ãšéææ§ã®ããã®æŠã
ãžã§ã³ãœã³æ°ã¯ã倧æè£œè¬äŒç€Ÿã®åºåè²»ãã¡ãã£ã¢å ±éã«åœ±é¿ãäžããŠãããšäž»åŒµãããããã®èª¿æ»çµæãäž»èŠãªãã¥ãŒã¹ãããã¯ãŒã¯ã«äŒããã®ã«èŠåŽããŠããŸãã圌ã¯ã補è¬äŒç€ŸãåŠæ¹è¬ã®åºåã«æ°ååãã«ãè²»ããã广çã«ã¡ãã£ã¢ã®ç©èªãè³Œå ¥ããŠãããšææããŸããã
ãªãã£ãŒãã»ãã«ã¡ã³ãœãŒã«äžé¢è°å¡(æ°äž»å ãã³ããã£ã«ããå·éžåº)ã¯ãå ¬èŽäŒã®åã«èšè äŒèŠãéããäžè¬ã®äººã ã«èŠãªãããä¿ããã
ãžã§ã³ãœã³æ°ã¯ãCOVID-19ãžã®å¯Ÿå¿ãæ¯æããã®ãšåãåœå±è ãã害ãåãŒããå¯èœæ§ã®ããæ±ºå®ã忀èšããããšã«æ¶æ¥µçã ãšäž»åŒµããŸããã
ãããªãã¯ãããªããæ¿èªããäœããããªãã人ã ã«æŒãä»ããäœãã圌ããæ®ºããããŸãã¯åœŒããæ°žä¹ ã«ç¡åã«ããããšãèªãããã§ãã?ããšãžã§ã³ãœã³ã¯å°ããã
ä¿¡é Œã®å±æ©ã¯èª¬æè²¬ä»»ãèŠæ±ããã
é·å¹Žã®ç£èп޻åãéããŠæããã«ãªã£ã蚌æ ã¯ãé£éŠæ¿åºã®ä¿å¥æ©é¢ãéææ§ãããç©èªãåªå ããŠãããšããåä»ãªç¶æ³ã瀺ããŠãããæå¶ãããå®å šæ§ã·ã°ãã«ããã黿¢ãããæå¹æ§ç ç©¶ãã¯ã¯ãã³ã§è² å·ããæ£è ã®ç§å¯æ²»çã«è³ããŸã§ããã®ãã¿ãŒã³ã¯ãç±³åœæ°ãå ¬è¡è¡çãå®ãããã«ä¿¡é ŒããŠããæ©é¢ã®äœç³»çãªå€±æã瀺åããŠããã
ã€ã³ãã©ãŒã ãã»ã³ã³ã»ã³ããšæ¿åºã®èª¬æè²¬ä»»ãéèŠãã人ã ã«ãšã£ãŠããããã®æŽé²ã¯ç¶ç¶çãªç²Ÿæ»ãå¿ èŠãšããŸããè°äŒãè£å€æãåœæ°ããããŸãã«ãé·ãéåŠå®ãããŠããéææ§ãèŠæ±ãããã©ãããšããåé¡ã¯æ®ã£ãŠããŸãããžã§ã³ãœã³æ°ãææããããã«ãCOVID-19ãžã®å¯Ÿå¿ãæ¯æããã®ãšåãåœå±è ã¯ãæ»äº¡ãŸãã¯æ°žç¶çãªé害ãåŒãèµ·ãããå¯èœæ§ã®ãã誀ããèªããåæ©ãã»ãšãã©ãããŸããã
éææ§ãæ±ããæŠãã¯ç¶ããŠãããFOIAã®èŠè«ãè°äŒã®å ¬èŽäŒãç¬ç«ãã調æ»ããé£éŠæ¿åºæ©é¢ãé èœããããšãããšãããçå®ãæããã«ããããã®äž»èŠãªææ®µãšãªã£ãŠããã